Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Anschütz M"'
Autor:
Christian Knopke, Ulrike Hanke, Marco Neumann, Christian Brätter, Werner Weitschies, Felix Schneider, Mirko Koziolek, Christiane Schiller, Barbara Schug, Knut Seidlitz, Claudia Heimhardt, Hanshermann Franke, Rudy Thoma, Frank Donath, Anschütz M
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 338
More than 50 years ago, the first gastroretentive dosage forms came up. Since then, no practical and at the same time reliable gastroretentive system is available on market. A major obstacle in the development of novel gastroretentive systems is the
Autor:
Erik Söderlind, Anschütz M, Barbara Schug, Bertil Abrahamsson, Christian Knopke, Susanna Abrahmsén-Alami, Anna Viridén, Henning Blume, Anette Welinder, Arun Kumar Jain, Werner Weitschies, Farhad Tajarobi, Stefan Nagel, Sara Richardson
Publikováno v:
Journal of Controlled Release. 187:50-58
Four different hydrophilic matrix formulations based on hydroxypropyl methylcellulose (HPMC) were investigated for erosion properties in vivo. Three formulations contained a fixed amount of HPMC (40%) with varying proportions of two HPMC grades with
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Surgery: ACA Acta Chirurgica Austriaca. Apr2015, Vol. 47 Issue 2, p53-55. 3p.
Publikováno v:
European Surgery: ACA Acta Chirurgica Austriaca. Apr2015, Vol. 47 Issue 2, p56-58. 3p.
Autor:
E. Brendel, K. Pauli, C Toal, M Wonnemann, Frank Donath, Henning Blume, A. Pontius, Barbara Schug, Anschütz M
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 48:158-170
This study was designed to evaluate and compare the bioavailability of two osmotically active formulations of 60 mg nifedipine, Gen-Nifedipine extended release Test tablets (Genpharm ULC, Etobicoke, ON, Canada) and Adalat XL Reference tablets (Bayer
Publikováno v:
Clinical Therapeutics. 30:48-58
Objective: The objective of this study was to compare the in vitro and in vivo characteristics of 2 nifedipine modified-release tablet formulations for once-daily dosing marketed in the European community, which were expected to be bioequivalent. Met
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
International journal of clinical pharmacology and therapeutics. 48(1)
Objective: N-acetyltransferase 2 (NAT2) genotype-phenotype relation with sulfasalazine as probe drug by means of detailed genotype analysis and kinetic data evaluation. Background: Though phenotype analysis of sulfasalazine metabolism has been descri
Autor:
Grzegorz Garbacz, Werner Weitschies, Barbara Schug, Henning Blume, Frank Donath, Olaf Kosch, Anschütz M, J Wiedmann, Lutz Trahms, W Hoeckh
Publikováno v:
Europe PubMed Central
Objectives Functional formulations providing protection of nutritional products against gastric juice or a capable of delivering them to distinct areas of the gastrointestinal tract are increasingly utilized by the food industry. However, the applica